コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ance (genome annotation, design of mutant or transgenic organisms).
2 logies has led to an explosion of mutant and transgenic organisms.
3 sufficient to confer glyphosate tolerance to transgenic organisms.
4 iana and evaluated the salt tolerance of the transgenic organisms.
5 bacterial cells grown in bioreactors and in transgenic organisms.
6 , functional genomics, and the generation of transgenic organisms.
7 on and oxidative stresses in Dsup-expressing transgenic organisms.
8 -limiting step in the design and creation of transgenic organisms.
9 then fused to reporter genes and assayed in transgenic organisms.
10 esirable to know the gene copy number of the transgenic organism and the zygosity of its offspring.
11 cle reviews the current uses of FPs in whole transgenic organisms and genomics and looks beyond GFP t
12 areas such as gene therapy, construction of transgenic organisms, and manipulation of cell lines.
13 o gene, rescued the cell division defects in transgenic organisms, and sequenced the genomic DNA.
14 we showed the practicality of deploying such transgenic organisms as an internal control to ascertain
15 es can be introduced into cells, tissues, or transgenic organisms by genetic manipulation, selectivel
18 Transposons are useful tools for creating transgenic organisms, insertional mutagenesis, and genom
19 l risk associated with the introduction of a transgenic organism is that the transgene, though rare,
21 by means of reporter constructs expressed in transgenic organisms is the most reliable method, but is
22 tities, but production approaches based upon transgenic organisms might be more cost-effective for la
23 P assays that either target RNA and DNA from transgenic organisms or target RNA exclusively and demon
25 level of containment required to consider a transgenic organism suitable for deployment is discussed
27 ency is often assumed to be unlikely because transgenic organisms typically have some viability disad